Business Description
Agilon Health Inc
NAICS : 623312
SIC : 8099
ISIN : US00857U1079
Total Employee Number:
856Compare
Compare
Traded in other countries / regions
AGL.USA Index Membership
Russell 2000Russell 3000Russell 1000 IPO Date
2021-04-15Description
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.93 | |||||
Equity-to-Asset | 0.12 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.21 | |||||
Beneish M-Score | -4.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.8 | |||||
3-Year EBITDA Growth Rate | -71.2 | |||||
3-Year EPS without NRI Growth Rate | -62.1 | |||||
3-Year FCF Growth Rate | 3.5 | |||||
3-Year Book Growth Rate | -50.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.38 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 71.16 | |||||
9-Day RSI | 68.35 | |||||
14-Day RSI | 68.87 | |||||
3-1 Month Momentum % | 795.69 | |||||
6-1 Month Momentum % | 369.94 | |||||
12-1 Month Momentum % | 47.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.18 | |||||
Days Sales Outstanding | 60.3 | |||||
Days Payable | 74.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.45 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -2.5 | |||||
Operating Margin % | -6.89 | |||||
Net Margin % | -6.09 | |||||
EBITDA Margin % | -5.79 | |||||
FCF Margin % | -1.47 | |||||
OCF Margin % | -0.86 | |||||
ROE % | -116.36 | |||||
ROA % | -22.11 | |||||
ROIC % | -154.51 | |||||
3-Year ROIIC % | 217.11 | |||||
ROC (Joel Greenblatt) % | -1119.51 | |||||
ROCE % | -101.21 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.34 | |||||
PB Ratio | 10.91 | |||||
Price-to-Tangible-Book | 16.63 | |||||
EV-to-EBIT | -4.9 | |||||
EV-to-EBITDA | -5.32 | |||||
EV-to-Revenue | 0.31 | |||||
EV-to-Forward-Revenue | 0.24 | |||||
EV-to-FCF | -20.98 | |||||
Price-to-GF-Value | 1.26 | |||||
Earnings Yield (Greenblatt) % | -20.41 | |||||
FCF Yield % | -4.29 |
Agilon Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Agilon Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 16:30 | In 130 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 129 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 16:30 | In 39 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 38 days | ||
| General meeting for 2025 | 2026-06-02 12:00 | 92.54 (+0.47%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 16:30 | 26.74 (-0.96%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 26.74 (-0.96%) | ||
| 0.04:1 Stock Split | 2026-03-31 | 8.04 (-18.41%) | ||
| 28th Annual Barclays Global Healthcare Conference | 2026-03-10 13:30 | 15.00 (+1.64%) | ||
| Jefferies Healthcare Services Innovation & Technology Summit | 2026-03-09 10:00 | 14.96 (-9.35%) |
Show
Entries
Guru Commentaries on NYSE:AGL
No articles.
Press Release
Articles on Agilon Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers